PMCPA
-
Pfizer receives PMCPA censure for providing business-class flights to UK HCPs
Ruling reinforces long‑standing Code of Practice expectations on appropriate hospitality, certification, and standards across the pharmaceutical industry.
-
PMCPA resolves Moderna case regarding tweets, articles about clinical trials
Actions by Moderna and associated third parties caused concern and ‘reflected poorly on the industry’.
-
Pfizer and Novo Nordisk rebuked over pharma payments
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.